Literature DB >> 11852345

Non-Hodgkin's lymphoma in a patient with probable hereditary nonpolyposis colon cancer: report of a case and review of the literature.

Kouichi Hirano1, Kaname Yamashita, Naoyuki Yamashita, Yasuto Nakatsumi, Hiroyasu Esumi, Atsuhiro Kawashima, Takahito Ohta, Masayoshi Mai, Toshinari Minamoto.   

Abstract

PURPOSE: Hereditary nonpolyposis colorectal cancer kindreds are frequently associated with cancers in various organs, including endometrium, stomach, and ovary. However, hematologic malignancy has rarely been reported in association with this cancer syndrome. We present here the case of a probable hereditary nonpolyposis colon cancer patient in whom non-Hodgkin's lymphoma developed after curative resection of colon cancer. Our experience with this rare case encouraged us to review the literature for reports indicating a possible relationship between these diseases.
RESULTS: A 52-year-old male whose family history was consistent with the criteria for hereditary nonpolyposis colon cancer underwent right hemicolectomy for ascending colon cancer. Histologically the tumor consisted of adenocarcinoma that was moderately differentiated with mucinous foci and that invaded beyond the muscularis propria. Neither metastasis nor lymphoma was found in paracolonic lymph nodes. Eight months after surgery, the patient developed non-Hodgkin's lymphoma of T-cell origin involving the ileum and lungs. Both colon cancer and lymphoma frequently showed microsatellite DNA instability, sharing alteration in a locus of chromosome 7 (D7S501).
CONCLUSION: A possible association of hematologic malignancy with hereditary nonpolyposis colon cancer reported in the literature, together with a report that MSH2-deficient mice are susceptible to malignant lymphoma, strongly supports the finding that this patient's lymphoma was related to hereditary nonpolyposis colon cancer. Overall, this case manifested a distinct clinical course similar to that observed in an animal model that is deficient in DNA mismatch repair machinery, thus providing scientific and clinical implications for understanding the molecular basis of these tumors and for critical management of hereditary nonpolyposis colorectal cancer patients, respectively.

Entities:  

Mesh:

Year:  2002        PMID: 11852345     DOI: 10.1007/s10350-004-6161-9

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  8 in total

Review 1.  Surveillance in Lynch syndrome.

Authors:  Jukka-Pekka Mecklin; Heikki J Järvinen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  Extracolonic manifestations of lynch syndrome.

Authors:  Brian J Bansidhar
Journal:  Clin Colon Rectal Surg       Date:  2012-06

3.  Multiple primary tumors: Colorectal carcinoma and non-Hodgkin's lymphoma.

Authors:  Diana A Pantoja Pachajoa; Marco Antonio Bruno; Fernando A Alvarez; Germán Viscido; Facundo Mandojana; Alejandro Doniquian
Journal:  Int J Surg Case Rep       Date:  2018-05-30

4.  Novel Genetic Markers for Early Detection of Elevated Breast Cancer Risk in Women.

Authors:  Bohua Wu; Yunhui Peng; Julia Eggert; Emil Alexov
Journal:  Int J Mol Sci       Date:  2019-09-28       Impact factor: 5.923

Review 5.  The role of DNA mismatch repair in immunotherapy of human cancer.

Authors:  Yuchen He; Luyuan Zhang; Ruoyu Zhou; Yumin Wang; Hao Chen
Journal:  Int J Biol Sci       Date:  2022-04-04       Impact factor: 10.750

6.  Germline variants of DNA repair genes in early onset mantle cell lymphoma.

Authors:  Xiaogan Wang; Yuqin Song; Wei Chen; Ning Ding; Weiping Liu; Yan Xie; Yinan Wang; Jun Zhu; Changqing Zeng
Journal:  Oncogene       Date:  2020-11-15       Impact factor: 9.867

7.  The implications of an incidental chronic lymphocytic leukaemia in a resection specimen for colorectal adenocarcinoma.

Authors:  Robert J Dennis; Justin C Alberts
Journal:  World J Surg Oncol       Date:  2007-10-30       Impact factor: 2.754

8.  Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells.

Authors:  Yulan Qing; Stanton L Gerson
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.